171 related articles for article (PubMed ID: 29126926)
21. SH3BP1-induced Rac-Wave2 pathway activation regulates cervical cancer cell migration, invasion, and chemoresistance to cisplatin.
Wang J; Feng Y; Chen X; Du Z; Jiang S; Ma S; Zou W
J Cell Biochem; 2018 Feb; 119(2):1733-1745. PubMed ID: 28786507
[TBL] [Abstract][Full Text] [Related]
22. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
Wen X; Liu S; Cui M
Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
[TBL] [Abstract][Full Text] [Related]
23. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
24. Propofol enhances the cisplatin-induced apoptosis on cervical cancer cells via EGFR/JAK2/STAT3 pathway.
Li H; Lu Y; Pang Y; Li M; Cheng X; Chen J
Biomed Pharmacother; 2017 Feb; 86():324-333. PubMed ID: 28011380
[TBL] [Abstract][Full Text] [Related]
25. Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.
Zhou J; Zhang Y; Zou X; Kuai L; Wang L; Wang J; Shen F; Hu J; Zhang X; Huang Y; Chen Y
Hum Gene Ther; 2020 Mar; 31(5-6):385-395. PubMed ID: 31870179
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.
Li N; Zhang W
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28246354
[TBL] [Abstract][Full Text] [Related]
28. The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.
Jia H; Song L; Cong Q; Wang J; Xu H; Chu Y; Li Q; Zhang Y; Zou X; Zhang C; Chin YE; Zhang X; Li Z; Zhu K; Wang B; Peng H; Hou Z
Oncogene; 2017 May; 36(19):2655-2666. PubMed ID: 27893714
[TBL] [Abstract][Full Text] [Related]
29. Stanniocalcin 2 promotes cell proliferation and cisplatin resistance in cervical cancer.
Wang Y; Gao Y; Cheng H; Yang G; Tan W
Biochem Biophys Res Commun; 2015 Oct; 466(3):362-8. PubMed ID: 26361149
[TBL] [Abstract][Full Text] [Related]
30. Preclinical evaluation of a new liposomal formulation of cisplatin, lipoplatin, to treat cisplatin-resistant cervical cancer.
Casagrande N; De Paoli M; Celegato M; Borghese C; Mongiat M; Colombatti A; Aldinucci D
Gynecol Oncol; 2013 Dec; 131(3):744-52. PubMed ID: 24029417
[TBL] [Abstract][Full Text] [Related]
31. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
32. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
33. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
34. The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation.
Zhang B; Song L; Cai J; Li L; Xu H; Li M; Wang J; Shi M; Chen H; Jia H; Hou Z
J Exp Clin Cancer Res; 2019 May; 38(1):205. PubMed ID: 31101117
[TBL] [Abstract][Full Text] [Related]
35. Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells.
Okada T; Murata K; Hirose R; Matsuda C; Komatsu T; Ikekita M; Nakawatari M; Nakayama F; Wakatsuki M; Ohno T; Kato S; Imai T; Imamura T
Sci Rep; 2013 Oct; 3():2899. PubMed ID: 24113164
[TBL] [Abstract][Full Text] [Related]
36. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract][Full Text] [Related]
37. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
[TBL] [Abstract][Full Text] [Related]
38. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
39. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.
Hirano G; Izumi H; Kidani A; Yasuniwa Y; Han B; Kusaba H; Akashi K; Kuwano M; Kohno K
Mol Cancer Res; 2010 Jun; 8(6):864-72. PubMed ID: 20530585
[TBL] [Abstract][Full Text] [Related]
40. Integral membrane protein 2A enhances sensitivity to chemotherapy via notch signaling pathway in cervical cancer.
Li Y; Wang J; Gao C; Hu Q; Mao X
Bioengineered; 2021 Dec; 12(2):10183-10193. PubMed ID: 34872446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
